Skip to main content
NVDA-2.45%AAPL+2.59%GOOGL+0.45%MSFT-0.04%AMZN-0.07%TSM-1.20%SPCX+1.15%AVGO-0.54%META-0.77%TSLA-0.64%SKHY-3.86%MU-4.52%BRK-B-0.16%LLY+0.40%JPM-0.53%WMT+0.12%AMD-2.80%V-0.31%XOM+0.85%ASMLa-1.66%JNJ+0.01%INTC-4.89%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.73%ABBV+0.69%BAC-0.47%CSCO-1.32%CVX-0.09%COST-0.15%KO+0.66%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.47%UNH-0.55%HSBA.L-1.30%DELL-3.92%PG+0.14%MS-0.99%GE-0.74%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.02%HD-1.60%0939.HK+1.66%GS-1.00%NZDJPY-2.57%AUDJPY-1.80%CHFJPY-1.58%NZDCAD-1.44%EURNZD+1.42%NZDUSD-1.38%GBPNZD+1.37%USDJPY-1.22%GBPJPY-1.21%EURJPY-1.20%CADJPY-1.15%NZDCHF-1.03%USDZAR+1.02%USDSEK+0.88%EURZAR+0.87%USDNOK+0.86%AUDNZD+0.80%GBPZAR+0.79%EURSEK+0.73%EURNOK+0.72%AUDCAD-0.68%AUDDKK-0.64%EURAUD+0.61%USDTHB+0.60%AUDUSD-0.58%GBPAUD+0.57%CHFSEK+0.57%CHFNOK+0.55%AUDSGD-0.53%USDMXN+0.44%CADCHF+0.42%USDPLN+0.41%GBPTRY+0.41%NZDSGD-0.40%EURCHF+0.38%USDCHF+0.37%GBPCHF+0.35%NOKJPY-0.34%GBPHKD+0.32%GBPMXN-0.28%SGDJPY+0.26%EURPLN+0.26%USDSGD+0.25%NZDMXN-0.23%AUDCHF-0.22%USDILS+0.16%EURHKD-0.16%USDDKK+0.15%USDTRY+0.11%PLNJPY+0.11%EURSGD+0.11%USDCNH+0.10%EURCZK-0.09%GBPCAD-0.08%AUDNOK+0.07%USDCAD-0.06%CHFSGD-0.06%EURCAD-0.05%USDCOP-0.04%EURGBP+0.03%EURCNH-0.03%GBPSGD+0.02%EURUSD+0.02%USDHKD+0.01%GBPUSD+0.01%EURDKK0.00%XPTUSD-5.82%UKOIL+5.74%USOIL+5.51%GAGUSD-5.16%XAGUSD-5.16%HG1-4.93%GAUUSD-1.33%XAUUSD-1.33%XNGUSD+1.26%S1+0.97%COTTON+0.95%W1+0.92%BTCUSD-1.60%ETHUSD-0.41%USDTUSD-0.03%XRPUSD-3.15%SOLUSD-2.06%TRXUSDT+0.18%ZECUSDT-8.90%DOGEUSD-3.20%XMRUSDT-0.36%LINKUSD-1.58%XLMUSD-1.64%BCHUSDT-10.50%LTCUSD-2.09%UNIUSD-2.09%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.44%TAOUSDT-5.35%AAVEUSD-2.69%DOTUSDT-2.18%ICPUSDT-2.12%ONDOUSDT-3.45%WLDUSDT-3.15%ATOMUSDT-3.73%ARBUSDT-0.36%JUPUSDT-4.67%INJUSDT-3.45%STXUSDT-3.80%FETUSDT-3.74%TIAUSDT-1.39%PYTHUSDT-1.39%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.69%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.55%IOTAUSDT-4.04%AXSUSDT-2.68%FARTCOINUSDT-4.54%EOSUSDT-3.15%DYDXUSDT-2.64%ORDIUSDT-1.16%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.45%AAPL+2.59%GOOGL+0.45%MSFT-0.04%AMZN-0.07%TSM-1.20%SPCX+1.15%AVGO-0.54%META-0.77%TSLA-0.64%SKHY-3.86%MU-4.52%BRK-B-0.16%LLY+0.40%JPM-0.53%WMT+0.12%AMD-2.80%V-0.31%XOM+0.85%ASMLa-1.66%JNJ+0.01%INTC-4.89%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.73%ABBV+0.69%BAC-0.47%CSCO-1.32%CVX-0.09%COST-0.15%KO+0.66%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.47%UNH-0.55%HSBA.L-1.30%DELL-3.92%PG+0.14%MS-0.99%GE-0.74%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.02%HD-1.60%0939.HK+1.66%GS-1.00%NZDJPY-2.57%AUDJPY-1.80%CHFJPY-1.58%NZDCAD-1.44%EURNZD+1.42%NZDUSD-1.38%GBPNZD+1.37%USDJPY-1.22%GBPJPY-1.21%EURJPY-1.20%CADJPY-1.15%NZDCHF-1.03%USDZAR+1.02%USDSEK+0.88%EURZAR+0.87%USDNOK+0.86%AUDNZD+0.80%GBPZAR+0.79%EURSEK+0.73%EURNOK+0.72%AUDCAD-0.68%AUDDKK-0.64%EURAUD+0.61%USDTHB+0.60%AUDUSD-0.58%GBPAUD+0.57%CHFSEK+0.57%CHFNOK+0.55%AUDSGD-0.53%USDMXN+0.44%CADCHF+0.42%USDPLN+0.41%GBPTRY+0.41%NZDSGD-0.40%EURCHF+0.38%USDCHF+0.37%GBPCHF+0.35%NOKJPY-0.34%GBPHKD+0.32%GBPMXN-0.28%SGDJPY+0.26%EURPLN+0.26%USDSGD+0.25%NZDMXN-0.23%AUDCHF-0.22%USDILS+0.16%EURHKD-0.16%USDDKK+0.15%USDTRY+0.11%PLNJPY+0.11%EURSGD+0.11%USDCNH+0.10%EURCZK-0.09%GBPCAD-0.08%AUDNOK+0.07%USDCAD-0.06%CHFSGD-0.06%EURCAD-0.05%USDCOP-0.04%EURGBP+0.03%EURCNH-0.03%GBPSGD+0.02%EURUSD+0.02%USDHKD+0.01%GBPUSD+0.01%EURDKK0.00%XPTUSD-5.82%UKOIL+5.74%USOIL+5.51%GAGUSD-5.16%XAGUSD-5.16%HG1-4.93%GAUUSD-1.33%XAUUSD-1.33%XNGUSD+1.26%S1+0.97%COTTON+0.95%W1+0.92%BTCUSD-1.60%ETHUSD-0.41%USDTUSD-0.03%XRPUSD-3.15%SOLUSD-2.06%TRXUSDT+0.18%ZECUSDT-8.90%DOGEUSD-3.20%XMRUSDT-0.36%LINKUSD-1.58%XLMUSD-1.64%BCHUSDT-10.50%LTCUSD-2.09%UNIUSD-2.09%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.44%TAOUSDT-5.35%AAVEUSD-2.69%DOTUSDT-2.18%ICPUSDT-2.12%ONDOUSDT-3.45%WLDUSDT-3.15%ATOMUSDT-3.73%ARBUSDT-0.36%JUPUSDT-4.67%INJUSDT-3.45%STXUSDT-3.80%FETUSDT-3.74%TIAUSDT-1.39%PYTHUSDT-1.39%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.69%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.55%IOTAUSDT-4.04%AXSUSDT-2.68%FARTCOINUSDT-4.54%EOSUSDT-3.15%DYDXUSDT-2.64%ORDIUSDT-1.16%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
NE

NeuroPace, Inc. (NPCE)

NASDAQ • Healthcare

$14.5
-$0.25 (-1.8%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$14.68
Previous Close$14.5
Day Range$14.41 - $14.77
Avg. Volume (3M)139.5K
Market Cap$476.9M
52 Week Range
$9.22$19.6
Next EarningsIn 54 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$22.8M100%
Gross Profitminus cost of goods$18.9M83%

In plain terms: out of every $100 in revenue, NeuroPace, Inc. currently loses $27.

Fundamentals & Financials

Revenue (TTM)
$98.8M
Net Income (TTM)
-$19.1M
EPS (TTM)
-$0.57
ROA (TTM)
-19.71%
Current Ratio
4.94

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+42.9%Q1 2026-$0.08
-5.3%Q2 2026-$0.2
+17.4%Q3 2026-$0.18
Next

Nov 3

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About NeuroPace, Inc.

NeuroPace, Inc. develops implantable neuromodulation technology for epilepsy care and trades on NASDAQ as NPCE. The healthcare company works in medical devices, centered on the RNS system for drug-resistant focal epilepsy, and generated $100.0 million of revenue in FY2025 across its United States hospital-facility customer base.

Name
NeuroPace, Inc.
CEO
Joel D. Becker
Website
www.neuropace.com
Industry
Healthcare
Year Founded
1997
Employees
220

Today's Snapshot

AI-generated

So far today, NPCE is trading 3.8% lower at 13.95, while its sector was flat.

Trading Volume

Below 10d avg (115.6K)

16K

vs S&P 500 Today

Strong Underperformance

-3.23%

Updated: September 10, 2026 at 16:50 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
NPCE displays a subdued technical profile: the current price near 13.99 is below many key moving averages and underneath both the VWAP and classic pivot, which weigh on near-term structure. Momentum indicators are mixed to neutral and the MACD is essentially flat, while the RSI sits below the midpoint so upside conviction is limited. Trend strength reads weak with an ADX in the low teens, even as OBV shows accumulation; volatility is moderate. Technical takeaway: despite some volume support, the balance of indicators points to a sell bias with limited trend confirmation.
All signals
  • EMA (5 indicators)$14.53 - $15.05
    Sell
  • RSI (14)42.76
    Neutral
  • Stochastic %K (14, 3, 3)39.93
    Neutral
  • MACD Level (12, 26)-0.07
    Neutral

Peers & Related Assets

CERSCerus Corporation
$2.51-1.2%
MASS908 Devices Inc.
$9.69-1.2%
RXSTRxSight, Inc.
$6.33-1.9%
ALDXAldeyra The
$1.5-2.6%
CVRXCVRx, Inc.
$2.83-3.4%
BWAYBrainsWay Ltd.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.